Leaders of Fangzi District, Weifang City, Shandong Province inspected seput
Release time:2021-05-23 Number of views:348

On May 23, 2021, Zhang Longjiang, deputy secretary of Fangzi District Party committee and head of Fangzi District, Weifang City, Shandong Province, together with the leading group of the district government, visited the company to investigate and understand the company's research projects, and conducted an in-depth discussion on the innovative blood lipid health management model set around the company's products to be listed.

At the meeting, Wang Wei, chairman of the board of directors of the company, Yan Guangmei, chief scientist, Lin Suizhen, general manager and Chen Jiesi, Minister of business development department, gave a detailed introduction to the company, team and project. The company focuses on the creation of new drugs for major cardiovascular and cerebrovascular diseases and central nervous system diseases. In combination with the government's advocacy of "prevention of diseases" and the urgent needs of the market, the company has developed safe and effective auxiliary lipid-lowering health products around the primary prevention and rehabilitation of cardiovascular and cerebrovascular diseases, and created a unique lipid health management model, which has been highly praised by the leaders of Fangzi District government. Zhang Longjiang district chief mentioned that the ultimate goal of "healthy Weifang, healthy China" is not only to provide the highest level of medical equipment, but to keep all residents healthy and free from diseases through policy guidance and education, which is why it is very important to go deep into the grass-roots health management.

Zhang Longjiang district head made highly consistent comments and questions on the company's research projects and the current medical situation in China. Professor Yan Guangmei answered Zhang Longjiang's questions one by one.

The meeting was held in a harmonious and warm atmosphere. Through this in-depth and wide-ranging meeting, the two sides carried out the health management of national blood lipid control, set up a health consultation and publicity mode with the characteristics of "people's livelihood project", and build a "blood lipid health management center" pioneered in China In order to control the level of people's blood lipids, reduce the incidence of cardiovascular and cerebrovascular events and medical expenses, we responded positively to the "healthy China 2030" proposed by general secretary Xi Jinping. Finally, Zhang Longjiang district chief highly agreed with the company's future development plan and expressed his hope for future cooperation.